Actual Medicinal Product (AMP) - Incruse Ellipta 55micrograms/dose dry powder inhaler (GlaxoSmithKline UK Ltd)
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Current Name | Incruse Ellipta 55micrograms/dose dry powder inhaler | 09-10-2014 | |
Summary
- Licensed Route
- Inhalation
- Availability Restrictions
- None
- Licensing Authority
- Medicines - MHRA/EMA
- EMA Indicator
Codes
| BNF | Start Date | End Date |
|---|---|---|
| Previous BNF 03010200 | Start Date 14-01-2015 | End Date 03-04-2022 |
| Code | Start Date | End Date |
|---|---|---|
| 27567911000001101 | 09-10-2014 |
Parent Products
-
VTMUmeclidinium bromide
-
VMPUmeclidinium bromide 65micrograms/dose dry powd...
-
AMP(Current) Incruse Ellipta 55micrograms/d... (Other AMPs)
-
-
Actual Medicinal Product Pack (AMPP) Information
| Pack Size | Indicative Price | Discontinued |
|---|---|---|
| 30 dose | 2750 |